LSI Europe

As we continue to spread the word about the global health threat of resistance to antibiotics during this World Health Organization #AntimicrobialResistance #AwarenessWeek, we are pleased to share that our video from #LSIEurope24 is now available. Find an excerpt on the topic below and watch the rest of our CEO's 9-minute presentation to hear how we plan to advance infection prevention in surgical implants. https://lnkd.in/d-K7ddFW #awareness #top10 #globalhealthcarechallenges #infectionprotection?#hylomorph #healthcare #medtech #healthcareinnovation

Ebenbuild, a Munich-based startup, is revolutionizing the treatment of acute respiratory distress syndrome (ARDS) through AI and physics. The company's proprietary software creates digital twin models of patients' lungs using computer tomography and AI. These models enable personalized and precise mechanical ventilation, helping physicians manage lung stress and reduce complications. Traditional methods rely on patient body weight, often leading to suboptimal results. Ebenbuild’s approach considers individual lung physiology, predicting harmful ventilation settings and allowing safer, customized adjustments. This innovation reduces the frequency of ventilator adjustments, saving time, and costs, and ultimately shortening the duration of artificial ventilation. Beyond ventilation, Ebenbuild is expanding its technology to drug research, aiming to optimize drug efficacy in lung treatment. By predicting how drugs will affect specific lung areas, the technology could enhance clinical trials, reduce costs, and improve patient outcomes. Want to learn more about Ebenbuild? Catch Kei Wieland Müller’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.

Last week Osteal Therapeutics announced positive 12-month results from their APEX clinical trials, evaluating VT-X7 KIT for treating periprosthetic joint infections (PJI) of the hip and knee. Their VT-X7 KIT demonstrated a higher success rate (71%) compared to the standard two-stage approach (52%) for treating periprosthetic joint infections (PJI) of the hip and knee. Patients treated with VT-X7 underwent revision surgery significantly faster, with a median time of just 7 days versus 98 days for standard treatment. Additionally, the VT-X7 approach reduced procedure duration by 62 minutes and lowered the overall burden of PJI by 71%, offering a more efficient and patient-friendly solution for these challenging infections. Want to learn more about Osteal Therapeutics? Catch David Thompson’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.

Earlier this week Qaelon Medical announced the completion of prototype development for the world’s first and only surgical leak detection platform. The latest-generation prototype detects leaks as small as 1 mm—smaller than a surgical staple—in just 30 seconds, setting a new benchmark for surgical safety. Qaelon's patented technology replaces traditional visual testing with a standardized, data-driven approach. Utilizing digital sensors and proprietary software, the platform employs advanced algorithms to identify leaks that other methods often miss. This rapid detection, typically within a minute, allows surgical teams to act immediately, potentially saving lives and reducing the $1.1 billion annual cost of managing surgical leaks in the U.S. Want to learn more about Qaelon Medical? Catch Liam J. Burns’s full studio interview from LSI Europe ‘24 on our website and YouTube channel. PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.

??? (Re)discover the speech given by Sebastien Ladet, CEO of Affluent Medical, at #LSIEurope24. Last September, Affluent Medical travelled to Sintra, Portugal, to take part in LSI Europe 24! It was an exceptional event that gave our teams the opportunity to talk to leading investors and world leaders in medical technology and healthcare. On this occasion, our CEO Sébastien Ladet took to the stage to give a detailed presentation of Affluent Medical's innovative solutions: biomimetic, minimally invasive and adjustable devices ???? It was also an opportunity to look back at Affluent Medical's ambition and the latest advances that have recently marked the company's history! ??? ???????? ?????????? ??????, ???????? ?? ???????????? ?????? ???? ?????? ?????? ?????????? ???????? ???????? ?????? ???? ???? ????????????, ???? ?????? ???????????? ?????????? ?????? ???????????????????? ?????????? ?????? ?????? ???????????????????????????? ???????????????? ???????? ???????????????? ?????? ????????????????????. ???????? ???????????????????? ?????????????? ?????????? ???? ?????????????????????????? ?????????????? ????????????????, ????????????????????, ?????? ??????????????????, ?????????????? ?????????? ???? ?????????? ???????? ?????????????????? ???? ?????????? ????????????????, ?????????????????? ?? $10 ?????????????? ???????????? ???????? ????????????-?????????? ????????????" ?? Press Play and discover an extract from his speech ??

Xeltis recently announced that the FDA's Center for Devices and Radiological Health (CDRH) has granted Breakthrough Device Designation to aXess?, its innovative vascular access graft. Designed for patients requiring hemodialysis, aXess? enables the creation of a permanent, living vessel by leveraging Xeltis’ proprietary Endogenous Tissue Restoration (ETR) platform. This transformative approach addresses the limitations of current options, offering hope for millions of individuals needing vascular access or cardiovascular replacements annually. Want to learn more about Xeltis? Catch Eliane Schutte’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.

Shela Health is a women's health startup redefining prenatal care through early prediction and precision recommendations for pregnancy complications. The company leverages cutting-edge AI models and multiomics—integrating genomics, proteomics, metabolomics, and microbiome data—to identify risks as early as the 12th week of pregnancy. This enables tailored interventions to prevent conditions like preeclampsia, preterm birth, and gestational diabetes. With a mission to transition women's healthcare from reactive to proactive, Shela Health provides expectant mothers with accurate risk assessments and personalized care plans. Their innovative platform combines clinical insights with biological data, empowering healthcare providers to enhance maternal and fetal outcomes. Want to learn more about Shela Health? Catch Sharon Handelman-Gotlib’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.

ArthroSave B.V. is developing the KneeReviver, a knee joint distraction system for younger patients with knee osteoarthritis. This innovative device offers an alternative to total knee replacement by promoting joint regeneration and delaying the need for prosthetic implants. The KneeReviver facilitates a procedure known as knee joint distraction, which temporarily unloads the knee joint to encourage tissue regeneration. The system consists of an external brace fixated to the bone with pins, creating space between the joint surfaces. The device remains in place for six weeks, regenerating the joint. Clinical studies have demonstrated that this six-week treatment can alleviate pain, improve joint function, and potentially delay the need for knee replacement surgery by up to ten years. Want to learn more about ArthroSave? Catch Karianne Lindenhovius’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.

It's great to be back at LSI Europe where our friend Scott Pantel welcomed our Ana Maiques to join our fourth summit in a row, this time in Sintra, Portugal! ?? In Ana's inspiring presentation, she introduced our #Starstym system, and how it will revolutionize personalized therapies for conditions like #epilepsy and depression. She then went on to join the #Neuromodulation panel with amazing industry leaders Dr. Andrei Miclea, Catherine Poulin-Filion, and Melissa Lezameta, during which they had a fascinating discussion about the challenges, ethics, and what drives innovation and investments. Check out the full recording of her presentation at LSI here to discover our latest advancements: https://lnkd.in/dMtzYbvm

Powerful Medical is using artificial intelligence to empower clinicians to accurately diagnose cardiovascular diseases and treat cardiac patients with higher confidence. The company's lead product, PMcardio, employs deep learning algorithms that have been trained on over one million ECG records to identify over 30 cardiac diagnoses from a single 12-lead ECG tracing. With the ability to interpret 12-lead ECGs in under five seconds, PMcardio delivers immediate diagnostic support, allowing for rapid clinical decision-making. The platform identifies 38 cardiovascular conditions and provides personalized treatment recommendations, making it a versatile and valuable tool for healthcare providers. Accessible as a smartphone app, web app, and integrable solution, PMcardio ensures seamless integration into various healthcare settings, simplifying ECG interpretation for medical professionals. Want to learn more about Powerful Medical? Catch Martin Herman’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.